|1.||Kostrub, Corwin F: 1 article (04/2011)|
|2.||Reyes, Noe: 1 article (04/2011)|
|3.||Aggen, James B: 1 article (04/2011)|
|4.||Dozzo, Paola: 1 article (10/2010)|
|5.||Moser, Heinz E: 1 article (10/2010)|
04/01/2011 - "Here we assess the in vivo efficacy of ACHN-490 against a variety of common pathogens in two murine models: the septicemia and neutropenic thigh models. "
04/01/2011 - "In animals infected with a gentamicin-susceptible strain of Pseudomonas aeruginosa, treatment with either ACHN-490 or gentamicin led to 100% survival at doses of 16 mg/kg and above in the septicemia model. "
04/01/2011 - "When its activity against a gentamicin-susceptible strain of Escherichia coli was tested in the septicemia model, ACHN-490 improved 7-day survival with a dose-response profile similar to that of gentamicin, with 100% survival seen at doses of 1.6 mg/kg of body weight and above. "
|3.||Body Weight (Weight, Body)
|4.||Urinary Tract Infections (Urinary Tract Infection)